Characterization of chemokine receptor utilization of viruses in the latent reservoir for human immunodeficiency virus type 1

Journal of Virology

Volumn 74, Issue 17, 2000, Pages 7824-7833

  Pierson, T ^a   Hoffman, T L ^a   Blankson, J ^a   Finzi, D ^a   Chadwick, K ^a   Margolick, J B ^a   Buck, C ^a   Siliciano, J D ^a   Doms, R W ^a   Siliciano, R F ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR5; INDINAVIR; LAMIVUDINE; NEVIRAPINE; RITONAVIR; SAQUINAVIR; STAVUDINE; ZIDOVUDINE;

ARTICLE; CELL FRACTIONATION; CONTROLLED STUDY; GENE; GENETIC ANALYSIS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LATENT PERIOD; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS INFECTION;

CD4-POSITIVE T-LYMPHOCYTES; GENE PRODUCTS, ENV; HIV INFECTIONS; HIV-1; HUMANS; RECEPTORS, CCR5; RECEPTORS, CXCR4; RNA, VIRAL; VIRUS LATENCY;

EID: 0033871164     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.17.7824-7833.2000     Document Type: Article

References (51)

1. Chemokine receptors as HIV-1 coreceptors: Roles in viral entry, tropism, and disease
2. In vivo HIV-1 infection of CD45RA+CD4+ T cells is established primarily by syncytium-inducing variants and correlates with the rate of CD4+ T cell decline
3. The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes
4. Active nuclear import of human immunodeficiency virus type 1 preintegration complexes
5. Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection
6. CD45RC isoforms define two types of CD4 memory T cells, one of which depends on persisting antigen
7. Highly purified CD25-resting T cells cannot be infected de novo with HIV-1
8. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection
9. + T cells to the cytopathic effects of infection with human immunodeficiency virus type 1 strain LAI
10. Early establishment of a pool of latently infected, resting CD4(+) T cells during primary HIV-1 infection
11. In vivo fate of HIV-1-infected T cells: Quantitative analysis of the transition to stable latency
12. Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy
13. Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes
14. Change in coreceptor use correlates with disease progression in HIV-1 infected individuals
15. Contingent genetic regulatory events in T lymphocyte activation
16. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia growth and development study, multicenter AIDS cohort study, multicenter hemophilia cohort study, San Francisco city cohort, ALIVE study
17. A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors
18. Integration of human immunodeficiency virus type 1 DNA in vitro
19. Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy
20. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy
21. Evidence that T cell activation is required for HIV-1 entry in CD4+ lymphocytes
22. Gene organization and promoter function for CC chemokine receptor 5 (CCR5)
23. HIV infection of CD45RA+ and CD45RO+ CD4+ T cells
24. Host control of HIV-1 parasitism in T cells by the nuclear factor of activated T cells
25. Progression to the G(1b) phase of the cell cycle is required for completion of human immunodeficiency virus type 1 reverse transcription in T cells
26. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiplyexposed individuals to HIV-1 infection
27. Viral DNA carried by human immunodeficiency virus type 1 virions
28. In vivo estimates of division and death rates of human T lymphocytes
29. Lifespan of human lymphocyte subsets defined by CD45 isoforms
30. Human immunodeficiency virus type 1 preintegration complexes: Studies of organization and composition
31. Cloning and analysis of the promoter region of CCR5, a coreceptor for HIV-1 entry
32. + T cells are infected in human immunodeficiency virus type 1-infected individuals
33. Reservoirs for HIV-1: Mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy
34. Effects of CCR5 and CD4 cell surface concentrations on infections by macrophage-tropic isolates of human immunodeficiency virus type 1
35. Chemokine receptor responses on T cells are achieved through regulation of both receptor expression and signaling
36. HIV does not replicate in naive CD4 T cells stimulated with CD3/CD28
37. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene
38. HIV-1 replication is controlled at the level of T cell activation and proviral integration
39. + T cells are infectible by human immunodeficiency virus but do not release virus after activation
40. Partial reverse transcripts in virions from human immunodeficiency and murine leukemia viruses
41. Cytokine signals are sufficient for HIV-1 infection of resting human T lymphocytes
42. A synthetic peptide inhibitor of human immunodeficiency virus replication: Correlation between solution structure and viral inhibition
43. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia
44. Loss of inducible virus in CD45RA naive cells after human immunodeficiency virus-1 entry accounts for preferential viral replication in CD45RO memory cells
45. CCR5 levels and expression pattern correlate with infectability by macrophagetropic HIV-1, in vitro
46. HIV-1 entry into quiescent primary lymphocytes: Molecular analysis reveals a labile, latent viral structure
47. Incompletely reverse-transcribed human immunodeficiency virus type 1 genomes in quiescent cells can function as intermediates in the retroviral life cycle
48. Intravirion reverse transcripts in the peripheral blood plasma of human immunodeficiency virus type 1-infected individuals
49. Nascent human immunodeficiency virus type 1 reverse transcription occurs within an enveloped particle
50. Reverse transcription takes place within extracellular HIV-1 virions: Potential biological significance
51. Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy